文献速递妇科肿瘤消化系统肿瘤

超灵敏检测循环LINE-1 ORF1p作为特异性多癌种生物标志物

Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker.
PubMed 文献 · Cancer Discov · 2023-01-01

研究通过工程化超灵敏数字免疫分析法检测血浆中10^-17 mol/L水平的ORF1p,在多种癌症中具有高特异性。血浆ORF1p有望用于卵巢癌早期检测、提升多分析物panel诊断性能、胃食管癌早期治疗反应监测,并对胃食管癌和结直肠癌的总生存期具有预后价值。

要点

  • 工程化超灵敏数字免疫分析法可检测血浆中10^-17 mol/L的ORF1p,所需血浆量低至25 μL。
  • 血浆ORF1p有望用于卵巢癌早期检测,并提升多分析物panel的诊断性能。
  • 血浆ORF1p可用于胃食管癌早期治疗反应监测,并对胃食管癌和结直肠癌总生存期有预后价值。

核心结论

  • ORF1p是一种多癌种生物标志物,有望用于疾病检测和监测。

研究设计与样本

  • 工程化超灵敏数字免疫分析法检测血浆中10^-17 mol/L的ORF1p浓度,所需血浆量低至25 μL。

主要发现

  • 血浆ORF1p有望用于卵巢癌早期检测。
  • 血浆ORF1p提升多分析物panel的诊断性能。
  • 血浆ORF1p提供胃食管癌早期治疗反应监测。
  • 血浆ORF1p对胃食管癌和结直肠癌的总生存期具有预后价值。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Improved biomarkers are needed for early cancer detection, risk stratification, treatment selection, and monitoring treatment response. Although proteins can be useful blood-based biomarkers, many have limited sensitivity or specificity for these applications. Long INterspersed Element-1 (LINE-1) open reading frame 1 protein (ORF1p) is a transposable element protein overexpressed in carcinomas and high-risk precursors during carcinogenesis with negligible expression in normal tissues, suggesting ORF1p could be a highly specific cancer biomarker. To explore ORF1p as a blood-based biomarker, we engineered ultrasensitive digital immunoassays that detect mid-attomolar (10-17 mol/L) ORF1p concentrations in plasma across multiple cancers with high specificity. Plasma ORF1p shows promise for early detection of ovarian cancer, improves diagnostic performance in a multianalyte panel, provides early therapeutic response monitoring in gastroesophageal cancers, and is prognostic for overall survival in gastroesophageal and colorectal cancers. Together, these observations nominate ORF1p as a multicancer biomarker with potential utility for disease detection and monitoring. SIGNIFICANCE: The LINE-1 ORF1p transposon protein is pervasively expressed in many cancers and is a highly specific biomarker of multiple common, lethal carcinomas and their high-risk precursors in tissue and blood. Ultrasensitive ORF1p assays from as little as 25 μL plasma are novel, rapid, cost-effective tools in cancer detection and monitoring. See related commentary by Doucet and Cristofari, p. 2502. This article is featured in Selected Articles from This Issue, p. 2489.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Taylor MS, Wu C, Fridy PC, et al. Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker. Cancer Discov. 2023. PMID: 37698949. doi:10.1158/2159-8290.CD-23-0313

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。